Multiple Sclerosis Clinical Trials

Showing 4181-4200 of 5,960 trials

Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes

NCT00104806

RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Cholecalciferol (vitamin D) may help cancer cells become normal cells. Giving arsenic trioxide together with cholecalciferol (vitamin D) may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving arsenic trioxide together with cholecalciferol (vitamin D) works in treating patients with myelodysplastic syndromes.

LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms

Wake Forest University Health Sciences5 participantsStarted Nov 2004

Winston-Salem, North Carolina, United States

COMPLETEDPhase 2

Cholecalciferol in Treating Patients With Myelodysplastic Syndrome

NCT00068276

RATIONALE: Cholecalciferol (vitamin D) may improve quality of life by increasing blood counts, decreasing fatigue, and improving other symptoms of myelodysplastic syndrome. PURPOSE: This phase II trial is studying how well cholecalciferol works in treating patients with myelodysplastic syndrome.

LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms

Wake Forest University Health SciencesStarted Jul 2003

Winston-Salem, North Carolina, United States

COMPLETEDNA

Connecticut Child STEPs

NCT03153904

Connecticut Child STEPS is a randomized controlled trail investigating the effectiveness of MATCH-ADTC in treating anxiety, depression, trauma, and/or behavioral problems in children seeking services at four Department of Children and Families (DCF) funded clinics in the state of Connecticut. The study will evaluate child outcomes following two forms of therapist training in the MATCH model.

AnxietyDepressionTrauma+1 more

Harvard University210 participantsStarted Oct 2013

Cambridge, Massachusetts, United States

Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes

Cholecalciferol in Treating Patients With Myelodysplastic Syndrome

Connecticut Child STEPs

Related Searches

Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients.

Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin Lesions

Comparing Interventions for Indoor Air -Related Functional Symptoms

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

Effect of Motor Entrainment to Auditory Cues and Music During Walking on Quality of Movement and Perceived Fatigue in Persons With Multiple Sclerosis (PwMS)

Brown Adipose Tissue Activity and Energy Metabolism in Cachexia

Feru-guard for Behavioral Symptoms in Dementia

SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization

Regorafenib Post-marketing Surveillance

The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib

Adenoma Detection Rate With Endocuff-Assisted Colonoscopy - an Italian Trial

Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors

Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy

Bio-psycho-social Pathways Underlying the Effects of Qigong Among Comorbid Depressed Elderly With Chronic Conditions

Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis

Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known

Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumors